Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
zQGtuhZ8SXRVW8wf
Listen
